Brief: Outlook Therapeutics® Announces Executive Leadership Transition
03/12/2024 22:52
Dec 3 (Reuters) - Outlook Therapeutics Inc OTLK.O :
* OUTLOOK THERAPEUTICS® ANNOUNCES EXECUTIVE LEADERSHIP
TRANSITION
* OUTLOOK THERAPEUTICS INC - LAWRENCE KENYON APPOINTED
INTERIM CEO
OF OUTLOOK THERAPEUTICS
* OUTLOOK THERAPEUTICS INC - RUSSELL TRENARY STEPS DOWN AS
CEO OF
OUTLOOK THERAPEUTICS
* OUTLOOK THERAPEUTICS INC - ENGAGES EXECUTIVE SEARCH FIRM
FOR
PERMANENT CEO
Source text: ID:nGNX69F1Qf
Further company coverage: OTLK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Outlook Therapeutics
See all newsBrief: Outlook Therapeutics Appoints Kevin Lundquist As Chief Financial Officer As It Prepares For U.S. Commercial Launch Of Lytenava™
Outlook Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Outlook Therapeutics Q3 net loss narrows slightly as costs drop
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce